Troxevasin, capsules 300 mg 100 pcs

Indications

Active ingredient

Composition

1 capsule:

– troxerutin 300 mg

Supplementary substances:

Lactose monohydrate – 47 mg,

Magnesium stearate – 3 mg.

Shell contents:

quinoline yellow dye (E104) – 0.9%,

sunset yellow dye (E110) – 0.039%,

titanium dioxide (E171) – 3%,

gelatin – up to 100%.

How to take, the dosage

To be taken orally with meals. Capsules should be swallowed whole with plenty of water.

In chronic venous insufficiency and its complications, in symptomatic treatment of hemorrhoids at the initial stage of treatment prescribe 1 capsule (300 mg) 2-3 times a day (600-900 mg) depending on the severity of symptoms. The effect usually develops within 2 weeks. Treatment is discontinued after symptoms and edema disappear.

If symptoms recur, treatment is resumed at the same dose or the dose is reduced to 1 capsule 2 times a day (600 mg).

The effect achieved lasts for at least 4 weeks. The average course of treatment is 3 to 4 weeks.

In diabetic retinopathy the drug is taken in a dose of 1800-3000 mg in 6-10 capsules (3-5 capsules (1800-3000 mg) twice daily). The course of treatment is 3-4 weeks on average.

The need for longer treatment is determined after consultation with the doctor and individually.

Interaction

Special Instructions

In the treatment of superficial thrombophlebitis or deep vein thrombosis, the use of the drug does not exclude the need to prescribe anti-inflammatory and antithrombotic therapy.

Troxerutin is ineffective in edema due to concomitant liver, kidney and heart disease.

If during the period of using the drug, symptoms of the disease do not decrease or become more severe, the patient should immediately see a physician. There is not enough experience of using the drug in children under 18 years of age. If using the drug alone, do not exceed the maximum periods and recommended doses.

Influence on driving and operating machinery

The use of the drug has no effect on motor and mental reactions and does not prevent driving vehicles and other complex mechanisms.

Synopsis

Contraindications

– Hypersensitivity to rutoside or other components of the drug.

– Pregnancy (I trimester).

– Gastric and duodenal ulcer.

– Chronic gastritis in the acute phase.

– Childhood under 18 years of age (experience of clinical use is insufficient).

– Period of breastfeeding.

– Rare hereditary galactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome.

With caution

– In renal failure (with long-term use).

– Pregnancy (II and III trimesters).

Side effects

The incidence of adverse reactions is given according to the WHO classification: very common (≥1/10), common (≥1/100, ˂1/10), infrequent (≥1/1000, ˂1/100), rare (≥1/10000, ˂1/1000), very rare (˂1/10000), frequency unknown (cannot be estimated based on available data).

Disorders immune system: very rarely – anaphylactic shock, anaphylactoid reactions, hypersensitivity reactions (eg, skin rash).

Disorders Nervous system disorders: very rarely – headache, dizziness.

Disorders vascular disorders: very rarely – hyperemia (“tides” of blood), ecchymosis.

Gastrointestinal tract disorders: very rarely – nausea, pain and discomfort in the stomach, dyspepsia, flatulence, diarrhea, erosive-ulcerative lesions of the gastrointestinal tract.

Skin and subcutaneous tissue disorders: sometimes – itching, rash, urticaria.

Others: very rarely – feeling of fatigue.

In case of adverse reactions, consult a doctor.

Overdose

Pregnancy use

Troxevasin should be used during pregnancy (II and III trimesters) and during lactation if the expected benefits to the mother outweigh the possible risks to the fetus and child.

Similarities